A  Mass Medical Angels

http://www.massmedangels.com





     Office Locations:

MA

 

Stages:

  • Early
  • Seed


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Mass Medical Angels (MA2) was founded to answer the need for a dedicated life-science centric angel group in New England. The group's focus is on early stage life science and healthcare companies looking to raise $250K to $3.0M. Depending on the amount of funding needed, MA2 can fund all or a portion of the round and will work closely with other angel groups or venture funds in the area to complete the round. The group is looking for companies that are extremely capital efficient opportunities where its funds will lead to significant step-ups in valuation to avoid unfavorable future funding rounds. MA2's target is a 5x return within 5 years. The group will consider investments in companies in medical devices, therapeutics, diagnostics, health services, health related IT, and healthcare-relevant laboratory instruments. The group's investment is targeted to be between $200,000 and $700,000. The fund was launched by Richard Anders, a long time Boston-area entrepreneur, publisher, and financier.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Carl Berke Co-Founder and Managing Director
    Penny Rossano Chair - Screening
    Pushwaz Virk Co-Founder
    Richard Anders Founder and Executive Director
    Richard Berenson Director

     

    Portfolio companies include:


      Avaxia
        web link


      Avaxia Biologics


      Bliss Healthcare


      Capillary Biomedical


      Daktari Diagnostics


      Diffinity Genomics


      InfoBionic
        web link


      Lantos Technologies


      Life Image


      Momelan Technologies


      Sage Science


      Sialix
        web link


      Thermalin Diabetes


     

    Recent News: